以岭药业1.1类新药芪防鼻通片获澳门中成药注册证书

Core Viewpoint - Yiling Pharmaceutical has received approval from the Macao Health Bureau for its innovative traditional Chinese medicine, Qifang Bitong Pian, marking a significant milestone in the development of traditional Chinese medicine in Macao [1][3]. Company Summary - Yiling Pharmaceutical's subsidiary, Yiling (Macao) Co., Ltd., has been granted the first registration certificate for an innovative traditional Chinese medicine by the Macao Health Bureau [1]. - Qifang Bitong Pian is designed to treat persistent allergic rhinitis, addressing symptoms such as sneezing, runny nose, nasal congestion, and fatigue [3]. - The company holds complete intellectual property rights for Qifang Bitong Pian, which is based on the theory of "lung and spleen deficiency" in allergic rhinitis treatment [3]. Industry Summary - The approval of Qifang Bitong Pian represents a new treatment option for patients with allergic rhinitis and revitalizes the application of traditional Chinese medicine in the field of otolaryngology [3]. - Yiling Pharmaceutical is leveraging modern high-tech innovations to drive the industrialization of traditional Chinese medicine, with 17 patented new drugs, including 11 listed in the national medical insurance directory [4]. - The company is advancing its research pipeline with two traditional Chinese medicines already submitted for production and six in clinical stages, alongside numerous hospital preparations as a reserve for new drug development [4].